Shares of Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) dropped 7.4% during mid-day trading on Monday . The stock traded as low as $0.40 and last traded at $0.40. Approximately 6,448 shares were traded during trading, a decline of 68% from the average daily volume of 20,342 shares. The stock had previously closed at $0.4320.
Cell MedX Stock Performance
The company’s fifty day moving average is $0.33 and its 200-day moving average is $0.35.
About Cell MedX
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Featured Stories
- Five stocks we like better than Cell MedX
- Stock Splits, Do They Really Impact Investors?
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- Do ETFs Pay Dividends? What You Need to Know
- The Best Local Butchers for Thanksgiving [2025 Survey]
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
